NICOLE TRAINOR: Open Payments
NPI 1568017812 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,855 in 92 payments from 16 companies in 2025. Trend: 2023 $1,907 · 2024 $1,661 · 2025 $1,855
Food & beverage: $1,814Education: $41
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $389 |
| Regeneron Healthcare Solutions, Inc. | 17 | $297 |
| GENZYME CORPORATION | 7 | $180 |
| CSL Behring | 11 | $159 |
| Genentech USA, Inc. | 11 | $151 |
| GlaxoSmithKline, LLC. | 8 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $118 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Amgen Inc. | 3 | $78 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $62 |
Products named: DUPIXENT, Xolair, TEZSPIRE, BREZTRI, Hizentra, FASENRA, NUCALA, AYVAKIT.
Industry payments across CO — which companies pay providers there.
